Precipio, Inc. — Director's Dealing 2013

Oct 3, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TRANSGENOMIC INC (TBIO)
CIK: 0001043961
Period of Report: 2013-09-30

Reporting Person: Kinnon Paul (Director, CEO and President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-09-30	Stock Option (Right to Buy)	$0.36	A	2150000	Acquired	2023-09-30	Common Stock (2150000)	Direct
2013-09-30	Stock Appreciation Rights	$0.36	A	1000000	Acquired	2023-09-30	Common Stock (1000000)	Direct

Footnotes

F1: The option was granted on 9/30/2013 and is exercisable as it vests. The option vests over a three-year period, with 1/3 of the shares subject to the option vesting on the first anniversary of the grant date and the balance vesting in 24 substantially equal installments thereafter, subject to the reporting person's continued employment with the issuer on each such date.

F2: The stock appreciation rights were granted on 9/30/2013 and are exercisable as they vest. The stock appreciation rights vest over a three-year period, with 34% of the shares subject to the stock appreciation rights vesting on the first anniversary of the grant date and the balance vesting ratably over the remaining 24 months, subject to the reporting person's continued employment with the issuer on each such date.